Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $79.9 billion.

  • Takeda Pharmaceutical's Non-Current Assets fell 171.22% to $79.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $79.9 billion, marking a year-over-year decrease of 171.22%. This contributed to the annual value of $77.0 billion for FY2025, which is 1153.43% down from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Non-Current Assets stood at $79.9 billion, which was down 171.22% from $78.4 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Non-Current Assets ranged from a high of $96.4 billion in Q1 2021 and a low of $76.9 billion during Q1 2025
  • For the 5-year period, Takeda Pharmaceutical's Non-Current Assets averaged around $85.0 billion, with its median value being $85.2 billion (2024).
  • In the last 5 years, Takeda Pharmaceutical's Non-Current Assets plummeted by 1412.22% in 2022 and then skyrocketed by 333.39% in 2023.
  • Over the past 5 years, Takeda Pharmaceutical's Non-Current Assets (Quarter) stood at $89.9 billion in 2021, then fell by 14.12% to $77.2 billion in 2022, then grew by 3.33% to $79.8 billion in 2023, then increased by 1.83% to $81.3 billion in 2024, then dropped by 1.71% to $79.9 billion in 2025.
  • Its Non-Current Assets was $79.9 billion in Q4 2025, compared to $78.4 billion in Q3 2025 and $79.4 billion in Q2 2025.